Is HURA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HURA. It does not provide personalized investment advice.

HURA (TuHURA Biosciences, Inc. Common Stock) Stock Analysis - Financials

TuHURA Biosciences, Inc. Common Stock (HURA) is a publicly traded Healthcare sector company. As of July 29, 2026, HURA trades at $2.04 with a market cap of $135.64M and a P/E ratio of -3.32. HURA moved -3.99% today. Year to date, HURA is +169.59%; over the trailing twelve months it is -23.88%. Its 52-week range spans $0.41 to $6.90. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces HURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are HURA's key financials?

HURA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HURA recently traded at $2.04. Market cap is $135.64M. P/E ratio is -3.32. Revenue is $0.

HURA Key Metrics

Key financial metrics for HURA
Metric	Value
Price	$2.04
Market Cap	$135.64M
P/E Ratio	-3.32
EPS	$-0.63
Dividend Yield	0.00%
52-Week High	$6.90
52-Week Low	$0.41
Volume	227.34K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-30.05M
Gross Margin	0.00%

HURA Analyst Consensus

1 analysts cover HURA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about HURA

What are HURA's key financials?: HURA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HURA recently traded at $2.04. Market cap is $135.64M. P/E ratio is -3.32. Revenue is $0.
Is HURA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HURA. It does not provide personalized investment advice.